Bioventus Inc.BVSNASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank75
5Y CAGR+9.0%
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

5Y CAGR
+9.0%/yr
Long-term compound
Percentile
P75
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202588.98%
2024373.43%
2023153.16%
2022-814.66%
2021-95.89%
202057.94%
2019-17.26%
20180.00%
20170.00%
20160.00%